Home›Search›Current Vascular Pharmacology

Current Vascular Pharmacology

Bentham Science Publishers · United Arab Emirates · Est. 1960

ISSN1570-1611eISSN1875-6212

SJR Q2✓ WOS SCIE✓ Scopus / SJR

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ WoS flagship (SCIE/SSCI/AHCI)78

✓ Corroboration (2 more)+12

Total90

Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

285

days submission → published

measured · last 17 articles · accept 116d

SJR Rank

Top 50% in field

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q2. Source: Clarivate Journal Citation Reports.

SJR Scorei

0.601

H-Indexi

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

0.661

Total Worksi

1,663

Total Citationsi

38,898

2yr Mean Citednessi

1.92

Open Impact Factor alternative

Aims & Scope✦ Compiled from public sources

Current Vascular Pharmacology publishes clinical and research-based reviews, original research articles, letters, debates, and drug clinical trial studies. The journal covers pharmacological strategies to prevent stroke, improve treatment outcomes, and promote recovery, as well as research on acute vascular disease treatment.

AI-compiled from public web sources · verify on publisher page →

General Information

Country / RegionUnited Arab Emirates

Primary LanguageEnglish

1st Year Published1960

FrequencySix No. A Year, 2010-

StatusActive (last: 2026)

Total Publications1,663

Publisher OrgBentham Science Publishers

Visit Journal Website

Submission Info

Peer Review—

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

6/12 · 50%

✅

Do you know the journal / publisher?

Bentham Science Publishers

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1570-1611 / 1875-6212

✅

Indexed in a trusted database?

WoS, Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

2.7k

2019

1.4k

2020

566

2021

218

2022

291

2023

152

2024

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Cardiology and Cardiovascular MedicineQ2

PharmacologyQ3

Subject Classification

Web of Science Categories

Peripheral Vascular DiseasesPharmacology & Pharmacy

Scopus Categories

PharmacologyCardiology and Cardiovascular Medicine

Research Topics (OpenAlex)

Lipoproteins and Cardiovascular HealthAntiplatelet Therapy and Cardiovascular DiseasesDiabetes, Cardiovascular Risks, and LipoproteinsBlood Pressure and Hypertension StudiesCancer, Lipids, and MetabolismPeripheral Artery Disease ManagementAtrial Fibrillation Management and OutcomesNitric Oxide and Endothelin EffectsVenous Thromboembolism Diagnosis and ManagementAtherosclerosis and Cardiovascular Diseases

Frequently asked questions about Current Vascular Pharmacology

Is Current Vascular Pharmacology a predatory journal?

PubScope has no integrity flags on record for Current Vascular Pharmacology: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 90/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Current Vascular Pharmacology?

Current Vascular Pharmacology is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 1.92.

Is Current Vascular Pharmacology indexed in Scopus and Web of Science?

Current Vascular Pharmacology is indexed in Web of Science, Scopus.